Jorge D Sanchez, MD | |
117 W 39th St, Sioux Falls, SD 57105-5732 | |
(605) 334-8000 | |
(605) 334-8001 |
Full Name | Jorge D Sanchez |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Neurology |
Location | 117 W 39th St, Sioux Falls, South Dakota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295701506 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 3708 (South Dakota) | Primary |
Entity Name | Monument Health Rapid City Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
The ability to tell time is fundamental to how humans interact with each other and the world. Timing plays an important role, for example, in our ability to recognize speech patterns and to create music. Patterns are an essential part of timing. The human brain easily learns patterns, allowing us to recognize familiar patterns of shapes, like faces, and timed patterns, like the rhythm of a song. But exactly how the brain keeps time and learns patterns remains a mystery.
Identifying and treating metabolic deficiencies in patients with treatment-resistant depression can improve symptoms and in some cases even lead to remission, according to new research from the University of Pittsburgh School of Medicine published online today in the American Journal of Psychiatry.
According to an annual survey released Tuesday by the George Institute for International Health that looks at research and development (R&D) funding of diseases that affect the developing world, the U.S. government in 2008 "remained the single biggest contributor as it again provided almost half of the total funding but the report notes developing countries like Brazil [and] India ... were becoming a growing force," AAP/Sydney Morning Herald reports (Rose, 12/15).
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jorge D Sanchez, MD Po Box 89432, Sioux Falls, SD 57109-9432 Ph: (605) 334-8000 | Jorge D Sanchez, MD 117 W 39th St, Sioux Falls, SD 57105-5732 Ph: (605) 334-8000 |
News Archive
The ability to tell time is fundamental to how humans interact with each other and the world. Timing plays an important role, for example, in our ability to recognize speech patterns and to create music. Patterns are an essential part of timing. The human brain easily learns patterns, allowing us to recognize familiar patterns of shapes, like faces, and timed patterns, like the rhythm of a song. But exactly how the brain keeps time and learns patterns remains a mystery.
Identifying and treating metabolic deficiencies in patients with treatment-resistant depression can improve symptoms and in some cases even lead to remission, according to new research from the University of Pittsburgh School of Medicine published online today in the American Journal of Psychiatry.
According to an annual survey released Tuesday by the George Institute for International Health that looks at research and development (R&D) funding of diseases that affect the developing world, the U.S. government in 2008 "remained the single biggest contributor as it again provided almost half of the total funding but the report notes developing countries like Brazil [and] India ... were becoming a growing force," AAP/Sydney Morning Herald reports (Rose, 12/15).
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
› Verified 4 days ago
Dr. Alex James Linn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave Ste 610, Sioux Falls, SD 57105 Phone: 605-322-8860 Fax: 605-322-8868 | |
Amber Olson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Sioux Falls, SD 57108 Phone: 605-322-4005 | |
Dr. Robert Floyd Nuss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W. 69th St., Ste. 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 | |
Sarah A Flynn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St, Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 Fax: 605-322-5704 | |
Mackenzie Mertz, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 W 49th St, Sioux Falls, SD 57105 Phone: 605-312-8700 | |
Georgiana Nuss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 W 49th St, Sioux Falls, SD 57105 Phone: 605-312-8700 | |
Hannah Statz Devries, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4400 W 69th St Ste 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 |